Finance

Lists
Why is 603538 up 5.51%?
Dive Deeper
603538:SHA
Ningbo Menovo Pharmaceutical Co Ltd
CN¥20.87
+5.51%
(+1.09) 1D
Nov 4, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603538...
Open
CN¥19.66
High
CN¥20.90
Low
CN¥19.58
Mkt. cap
6.72B
Avg. vol.
35.69M
Volume
37.05M
Dividend
0.53%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
63.41
52-wk high
CN¥50.28
52-wk low
CN¥13.55
EPS
CN¥0.33
Shares outstanding
149.13M
No. of employees
2K
Open
CN¥19.66
High
CN¥20.90
Low
CN¥19.58
Mkt. cap
6.72B
Avg. vol.
35.69M
Volume
37.05M
Dividend
0.53%
Quarterly dividend
CN¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
63.41
52-wk high
CN¥50.28
52-wk low
CN¥13.55
EPS
CN¥0.33
Shares outstanding
149.13M
No. of employees
2K
News stories
From web sources and news partners
About Ningbo Menovo Pharmaceutical Co Ltd
CEO-
Employees2.37K
FoundedFeb 19, 2004
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
386.33M
337.65M
521.17M
581.89M
Cost of goods sold
264.93M
246.07M
358.46M
442.57M
Cost of revenue
264.93M
246.07M
358.46M
442.57M
Research and development expenses
45.05M
9.59M
29.20M
32.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.07M
43.79M
52.68M
60.93M
Operating expense
122.37M
47.60M
93.06M
81.77M
Total operating expenses
387.30M
293.67M
451.52M
524.34M
Operating income
-974.95K
43.98M
69.65M
57.55M
Other non operating income
-4.04M
-9.70M
6.71M
-37.06M
EBT including unusual items
11.60M
37.14M
53.22M
43.74M
EBT excluding unusual items
-14.36M
35.96M
61.02M
42.42M
Income tax expense
6.62M
4.67M
20.10M
3.41M
Effective tax rate
57.06%
12.57%
37.77%
7.79%
Other operating expenses
14.54M
-3.13M
4.72M
-7.91M
Net income
6.30M
31.16M
32.53M
40.43M
Net profit margin
1.63%
9.23%
6.24%
6.95%
Earnings per share
-
-
-
-
Interest and investment income
-
12.36M
3.20M
7.47M
Interest expense
-5.68M
-10.67M
-1.88M
-2.21M
Net interest expenses
-5.68M
1.68M
1.33M
5.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.08M
77.03M
104.33M
90.60M
Gain or loss from assets sale
142.66K
-
1.02M
-1.02M
Upcoming events
AI content may include mistakes. Learn more
Google apps